Research Article of International Journal of Aging Research
Telomere Length in Cystic Fibrosis Patients – Are Patients with CF Ageing Too Quickly?
Iona Ashworth1, Kevin Norris1 ,Lena Thia2, John A Dodge3, Julia W. Grimstead1, Rhiannon E. Jones1, Julian Forton2, Ann Smith5, Daniel Farewell5, Duncan M. Baird1, Jamie Duckers4
1Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, CF14 4XN
2 Noah’s Ark Children’s Hospital, University Hospital Wales, Cardiff UK CF14 2XX
3 Department of Paediatrics, Swansea University
4 All Wales Adult CF Centre, University Hospital Llandough, UK CF64 2XX
5 Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, CF14 4YS
Life expectancy for patients living with Cystic Fibrosis (CF) is increasing year on year and there is growing interest in the ageing process in CF. Telomeres are repetitive sequences of DNA that cap the ends of eukaryotic chromosomes and shorten with ongoing cell division, thus providing a marker of replicative history and biological ageing. We aimed to investigate whether telomere length as a function of age differs between patients with CF and healthy individuals and whether telomere length is associated with severity of the patient’s CF condition.
Peripheral blood samples and demographic data were collected from 47 consenting patients (age 1 to 57 years) with CF attending their routine annual review appointment at the All Wales Adult CF Centre and Noah’s Ark Children’s’ Hospital in Cardiff, UK. Telomere length profiles were assessed from peripheral blood samples, using the high resolution single telomere length analysis technique (STELA) and compared to healthy control telomere length data.
Patients with CF had significantly shorter telomere lengths than healthy individuals, when adjusting for age (p<0.001). Telomere length is decreasing 70% more quickly in the CF cohort than healthy controls. Telomere length does not appear to correlate with markers of disease severity.
Telomere lengths are significantly shorter in individuals with CF than in the age-adjusted healthy population. This is suggestive of premature biological ageing of peripheral blood leukocytes in CF patients.
Keywords: Ageing, telomere, inflammation
How to cite this article:
Iona Ashworth, Kevin Norris ,Lena Thia, John A Dodge, Julia W. Grimstead, Rhiannon E. Jones, Julian Forton, Ann Smith, Daniel Farewell, Duncan M. Baird, Jamie Duckers.Telomere Length in Cystic Fibrosis Patients – Are Patients with CF Ageing Too Quickly? . International Journal of Aging Research, 2021, 4:90. DOI: 10.28933/ijoar-2021-06-2005
1. Dodge JA, Lewis PA, Stanton M, Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J. 2007;29:522-6.
2. Simmonds NJ. Ageing in cystic fibrosis and long-term survival. Paediatr Respir Rev. 2013;14 Suppl 1:6-9.
3. Maisonneuve P, Marshall BC, Knapp EA, Lowenfels AB. Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States. J Natl Cancer Inst. 2013;105:122-9.
4. de Lange, T :Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005 19, 2100-2110
5. Liddiard K, Ruis B, Takasugi T, Harvey A, Ashelford KE, Hendrickson EA, et al. Sister chromatid telomere fusions, but not NHEJ-mediated inter-chromosomal telomere fusions, occur independently of DNA ligases 3 and 4. Genome Res. 2016;26:588-600.
6. Jones RE, Oh S, Grimstead JW, Zimbric J, Roger L, Heppel NH, et al. Escape from Telomere-Driven Crisis Is DNA Ligase III Dependent. Cell reports. 2014;8:1063-76.
7. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature. 2000;406:641-5.
8. Lin TT, Norris K, Heppel NH, Pratt G, Allan JM, Allsup DJ, et al. Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease. Br J Haematol. 2014;167:214-23.
9. Roger L, Jones RE, Heppel NH, Williams GT, Sampson JR, Baird DM. Extensive telomere erosion in the initiation of colorectal adenomas and its association with chromosomal instability. J Natl Cancer Inst. 2013;105:1202-11.
10. Jones CH, Pepper C, Baird DM. Telomere dysfunction and its role in haematological cancer. Br J Haematol. 2012;156:573-87.
11. Kolquist KA, Ellisen LW, Counter CM, Meyerson M, Tan LK, Weinberg RA, Haber DA, Gerald WL. 1998. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat Genet 19: 182-186
12. Andrew T, Aviv A, Falchi M, et al. Mapping genetic loci that determine leukocyte telomere length in a large sample of unselected female sibling pairs. Am J Hum Genet. 2006;78:480–486
13. Vasan RS, Demissie S, Kimura M, et al. Association of leukocyte telomere length with circulating biomarkers of the renin-angiotensin-aldosterone system: the Framingham Heart Study. Circulation. 2008;117:1138–1144
14. Sabharwal S, Verhulst S, Guirguis G, Kark JD, Labat C, Roche NE, et al. Telomere length dynamics in early life: the blood-and-muscle model. FASEB J. 2018;32:529-34.
15. Blasco MA. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet. 2005;6:611-22.
16. Caerphilly and Speedwell collaborative heart disease studies. The Caerphilly and Speedwell Collaborative Group”. Journal of Epidemiology and Community Health. 38 (3): 259–62. September 1984.
17. Capper R, Britt-Compton B, Tankimanova M, Rowson J, Letsolo B, Man S, et al. The nature of telomere fusion and a definition of the critical telomere length in human cells. Genes Dev. 2007;21:2495-508.
18. Parkins MD, Parkins VM, Rendall JC, Elborn S. Changing epidemiology and clinical issues arising in an ageing cystic fibrosis population. Ther Adv Respir Dis. 2011;5:105-19.
19. Hull JH, Garrod R, Ho TB, Knight RK, Cockcroft JR, Shale DJ, et al. Increased augmentation index in patients with cystic fibrosis. Eur Respir J. 2009;34:1322-8.
20. Effros R.B. Telomere/telomerase dynamics within the human immune system: Effect of chronic infection and stress. Exp. Gerontol. 2011;46:135–140
21. Kordinas V, Ioannidis A, Chatzipanagiotou S. The Telomere/Telomerase System in Chronic Inflammatory Diseases. Cause or Effect? Genes (Basel). 2016;7.
22. Ovadya Y, Krizhanovsky V Senescent cells: SASPected drivers of age-related pathologies Biogerontology. 2014 Dec;15(6):627-42
This work and its PDF file(s) are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.